Social Media Allows Patients to Discuss Less Frequent GLP-1 Adverse Effects

The landscape of pharmacovigilance is shifting as researchers increasingly look toward social media to uncover patient experiences that traditional clinical trials might miss. A recent large-scale analysis of over 410,000 Reddit posts between 2019 and 2025 provided a look at the real-world adverse effects of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), specifically semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound, Mounjaro). Among the 67,008 self-identified users in the study, approximately 43.5% reported experiencing at least 1 adverse effect, ranging from well-documented gastrointestinal issues to emerging signals that have yet to appear on standard drug labels.¹

“Pharmacists can tell patients that [gastrointestinal] issues such as nausea, vomiting, diarrhea, and constipation remain the most common adverse effects from GLP-1 therapies, but other uncommon adverse effects can always happen, so to report any new signs and symptoms after starting the medication therapy, there is no delay in reports of potential adverse effects,” Hailey Choi, PharmD, BCACP, CDCES, an associate professor of pharmacy practice at Massachusetts College of Pharmacy and Health Sciences, said in an interview.

About the Findings of the Study

Although gastrointestinal symptoms such as nausea and vomiting predominated the data, reporting at 36.9% and 16.3%, respectively, the study highlighted fatigue as the second most reported symptom at 16.7%. This finding is particularly significant for pharmacy professionals, as fatigue has met reporting thresholds in relatively few clinical trials despite its high prevalence in real-world patient discussions.¹

“This is very interesting because I just encountered a patient at the clinic today who has been complaining about extreme fatigue since the initiation of GLP-1 therapy and trying to figure out whether this is from GLP-1 medication or something else,” Choi said. “It can be multifactorial, such as directly from the medication itself but also from reduced caloric intake or metabolic changes due to too-rapid weight loss.”

Beyond the common complaints, this Reddit-based analysis identified several hypothesis-generating signals that could change how pharmacists counsel patients on GLP-1 RAs. For instance, nearly 4% of users reporting adverse effects described reproductive symptoms, such as intermenstrual bleeding and irregular menstrual cycles. Researchers suggest these symptoms warrant further investigation because GLP-1 RAs may engage receptors in the hypothalamus, a brain region central to menstrual regulation.¹

Additionally, some users described symptoms linked to altered temperature regulation, such as chills and hot flushes, which are not currently featured in the FDA-approved prescribing information for these medications. These findings suggest that physicians may soon encounter an increase in patient inquiries regarding these specific, lesser-known physiological changes.¹

Social Media for Health Care

This type of data collection, known as infoveillance, allows health care institutions and professionals to monitor public responses to health issues and predict potential risks in real-time. Social media platforms like Reddit offer a unique, context-rich environment where patients feel free to disclose sensitive or stigmatized medical experiences anonymously.^1,2

“Social media platforms like Reddit can serve as a valuable complementary tool for pharmacovigilance by capturing patient-reported experiences that may not be reflected in traditional reporting systems. In the US, adverse events are often reported through the FDA Adverse Event Reporting System, which largely relies on health care professionals and, to a lesser extent, patients to voluntarily submit reports,” Choi added.

She mentioned that many patients, especially those who have sensitive or stigmatized symptoms, might not bring them up during a clinical visit to formally report them. Social media can create a more open and anonymous environment where patients might be more willing to share information.

“That said, these data should be used cautiously. Social media lacks standardized reporting, cannot establish causality, and may be subject to bias or misinformation,” Choi said. “Therefore, its role is best viewed as hypothesis-generating, helping researchers and regulators identify areas that warrant further investigation through more rigorous study designs.”

The Pharmacist’s Role

The role of the pharmacist as a trustworthy source of information is more critical than ever in this digital era. Professionals are encouraged to establish interpersonal relationships with patients and invite conversations about the medical information—and potential misinformation—they encounter online. When addressing patient concerns derived from social media, pharmacists can help navigate demographic biases, as Reddit users tend to be younger and disproportionately located in the United States.^2,3

“Pharmacists should acknowledge patients’ concerns without dismissing it while carefully reviewing scientific evidence. If a patient is experiencing uncommon adverse events that have not been reported in clinical trials but have been discussed in an online community, we can assess timing, severity, alternative explanations, and potential drug interactions,” Choi said. “This keeps the conversation evidence-based while also validating the patient’s experience. We may have to go through a trial of holding medication and monitoring for symptom resolution.”

Furthermore, as health care organizations develop their own social media strategies to disseminate accurate information, they must remain vigilant about HIPAA compliance and the protection of patient privacy. Unauthorized disclosures of protected health information on social media, even if accidental, can lead to significant legal penalties and a loss of public trust.³

By staying informed on emerging patient-reported concerns, pharmacy professionals can provide more nuanced patient counseling and contribute to the broader goal of safer, more responsive pharmaceutical care. As digital technologies continue to evolve, the ability to humanly review and validate information for accuracy will remain the cornerstone of effective health care communication.¹

“Patients may be more comfortable sharing what they have read in online communities or reporting uncommon adverse effects with pharmacists than with other health care professionals,” Choi concluded. “This positions pharmacists uniquely to bridge the gap by combining evidence-based counseling with attentive, patient-centered listening.”

READ MORE: Diabetes Resource Center

Are you ready to elevate your pharmacy practice? Sign up today for our free Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips straight to your inbox.

REFERENCES

1. Sehgal NKR, Tronieri JS, Ungar L, Guntuku SC.Self-reported side effects of semaglutide and tirzepatide in online communities. Nat. Health (2026). doi:https://doi.org/10.1038/s44360-026-00108-y

2. Chen J, Wang Y. Social Media Use for Health Purposes: Systematic Review. J Med Internet Res. 2021;23(5):e17917. Published 2021 May 12. doi:10.2196/17917

3. Alder S. Social media in healthcare. The HIPPA Journal. August 22, 2024. Accessed April 23, 2026. https://www.hipaajournal.com/social-media-in-healthcare/